BioDelivery Sciences International (BioDelivery Sciences International) Inventory Turnover : 0.30 (As of Dec. 2021)

View and export this data going back to 2002. Start your Free Trial

What is BioDelivery Sciences International Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. BioDelivery Sciences International's Cost of Goods Sold for the three months ended in Dec. 2021 was $6.9 Mil. BioDelivery Sciences International's Average Total Inventories for the quarter that ended in Dec. 2021 was $23.4 Mil. BioDelivery Sciences International's Inventory Turnover for the quarter that ended in Dec. 2021 was 0.30.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioDelivery Sciences International's Days Inventory for the three months ended in Dec. 2021 was 309.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioDelivery Sciences International's Inventory-to-Revenue for the quarter that ended in Dec. 2021 was 0.54.

BioDelivery Sciences International Inventory Turnover Historical Data

The historical data trend for BioDelivery Sciences International's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Inventory Turnover Chart

BioDelivery Sciences International Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Inventory Turnover

Get a 7-Day Free Trial

4.12

2.75

2.58

1.72

1.14

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Inventory Turnover	Get a 7-Day Free Trial															0.46	0.34	0.24	0.31	0.30

BioDelivery Sciences International Inventory Turnover Calculation

BioDelivery Sciences International's Inventory Turnover for the fiscal year that ended in Dec. 2021 is calculated as

	Inventory Turnover (A: Dec. 2021 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2021 )	/ (	(Total Inventories (A: Dec. 2020 )	+	Total Inventories (A: Dec. 2021 ))	/	count )
=	23.373	/ (	(17.443	+	23.711)	/	2 )
=	23.373	/	20.577
=	1.14

BioDelivery Sciences International's Inventory Turnover for the quarter that ended in Dec. 2021 is calculated as

	Inventory Turnover (Q: Dec. 2021 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2021 )	/ (	(Total Inventories (Q: Sep. 2021 )	+	Total Inventories (Q: Dec. 2021 ))	/	count )
=	6.903	/ (	(23.075	+	23.711)	/	2 )
=	6.903	/	23.393
=	0.30

BioDelivery Sciences International (NAS:BDSI) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioDelivery Sciences International's Days Inventory for the three months ended in Dec. 2021 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2021 )	/	Cost of Goods Sold (Q: Dec. 2021 )	*	Days in Period
	=	23.393	/	6.903	*	365 / 4
	=	309.23

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioDelivery Sciences International's Inventory to Revenue for the quarter that ended in Dec. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2021 )	/	Revenue (Q: Dec. 2021 )
	=	23.393	/	43.154
	=	0.54

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

BioDelivery Sciences International Inventory Turnover Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (BioDelivery Sciences International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (NAS:BDSI) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

Executives

James Vollins	officer: See Remarks	C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARK LAKE AVE SUITE 225, RALEIGH NC 27607
Mark A Sirgo	director	C/O BIODELIVERY SCIENCES INTERNATIONAL, 801 CORPORATE CENTER DRIVE -SUITE 210, RALEIGH NC 27607
Broadfin Healthcare Master Fund Ltd	director	C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Kevin Kotler	director	C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Mary Theresa Coelho	officer: See Remarks	52 SUNRISE PARK ROAD, NEW HAMPTON NY 43017
Jeffrey Allen Bailey	director, officer: Chief Executive Officer	BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Todd C Davis	director	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
W. Mark Watson	director	324 S. HYDE PARK AVENUE, STE 350, TAMPA FL 33606
Peter Greenleaf	director	ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Broadfin Capital, Llc	director	300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Vanila Singh	director	C/O BIODELIVERY SCIENCES INTERNATIONAL, 4131 PARKLAKE AVE., SUITE 225, RALEIGH NC 27612
Scott M. Plesha	officer: See Remarks	1410 SMYTHE ST DANIEL ISLAND SC 29492
Odonnell Francis E Jr	director	BIODELIVERY SCIENCES INTERNATIONAL, INC, 4131 PARKLAKE AVENUE, SUITE #225, RALEIGH NC 27612
Herm Cukier	director, officer: Chief Executive Officer	C/O BIODELIVERY SCIENTES INT., INC. 4131 PARKLAKE AVE, SUITE 225 RALEIGH NC 27612
Thomas B Smith	officer: Chief Medical Officer	BIODELIVERY SCIENCES INTERNATIONAL, INC., 4131 PARKLAKE AVE SUITE 225, RALEIGH NC 27612